Envoy Medical COCH Induced Conversion Of Series A Preferred Stock Into Common Stock
Induced Conversion Of Series A Preferred Stock Into Common Stock at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept coch:InducedConversionOfSeriesAPreferredStockIntoCommonStock.
The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's induced conversion of series a preferred stock into common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's induced conversion of series a preferred stock into common stock?
- Envoy Medical (COCH) reported induced conversion of series a preferred stock into common stock of $290.5K in Q4 2024.
- What does induced conversion of series a preferred stock into common stock mean?
- Represents the incremental value or additional consideration provided by the company to encourage holders of preferred stock to convert their holdings into common equity before the original contractual maturity or terms. This activity is often used to simplify the capital structure or reduce future dividend obligations. It highlights management's strategy regarding capital structure optimization and the cost of accelerating equity conversion.